Table 2

Primary outcomes

Proportion (%), unless otherwise specifiedGroup 1
(n=15)
Group 2
(n=15)
Group 3
(n=16)
Total
(n=46)
Number of diaries with some data points entered by participant by end of participant follow-up15
(100%)
13
(86.7%)
13
(81.3%)
41
(89.1%)
Number of diaries fully completed by participant by end of participant follow-up13
(86.7%)
10
(66.7%)
9
(56.3%)
32
(69.6%)
Paper diaries issued due to failure of electronic diary0
(0%)
0
(0%)
0
(0%)
0
(0%)
Number randomised as a proportion of the target recruitment number46/45
(102.2%)
Number randomised as a proportion of invited participants46/120
(38.3%)
Number randomised as a proportion of eligible participants46/67
(68.7%)
 No of patients invited120
 No of patients eligible67
 No of participants enrolled15151646
 No of participants randomised15151646
 No of recruited per month (n)9.2
Number of participants lost to follow-up0
(0%)
2
(13.3%)
1
(6.3%)
3
(6.5%)
Number of participants withdrawing from study0
(0%)
0
(0%)
2
(12.5%)
2
(4.4%)
Side effects or problems related to cranberry consumption
 Yes0/13
(0%)
0/10
(0%)
1/11
(9.1%)
1/34 (2.9%)
 No1/13
(7.7%)
10/10
(100%)
10/11 (90.9%)21/34 (61.8%)
 Not applicable12/13 (92.3%)0/10
(0%)
0/11
(0%)
12/34 (35.3%)
 Missing2/155/155/1612/46
Problems completing the electronic diary
 No problem14/14 (100%)9/10
(90%)
9/11
(81.8%)
32/35 (91.4%)
 Some problems0/14
(0%)
1/10
(10%)
2/11
(18.2%)
3/35 (8.6%)
 Lots of problems0/14
(0%)
0/10
(0%)
0/11
(0%)
0/35
(0%)
 Missing1/155/155/1611/46
Problems using the scale of 0–50
 No problem12/14 (85.7%)9/9
(100%)
10/12 (83.3%)31/35 (88.6%)
 Some problems2/14 (14.3%)0/9
(0%)
2/12
(16.7%)
4/35 (11.4%)
 Lots of problems0/14
(0%)
0/9
(0%)
0/12
(0%)
0/35
(0%)
 Missing1/156/154/1611/46
Proportion of invited GP practices agreeing to participate in the trial5/5
(100%)
Proportion of invited GP practices opened and recruiting to the trial4/5
(80%)
Acceptability of the study to participants and recruiters, participants’ experience of having a UTI and thoughts on self-help for UTIsInterviews with trial participants and recruiters will be reported elsewhere.
  • Group 1—immediate antibiotics alone (control); group 2—immediate antibiotics and immediate cranberry; group 3—immediate cranberry and delayed antibiotics.

  • GP, general practitioner; UTI, urinary tract infection.